Zoekresultaten - Portaal voor medische datamodellen (MDM-portaal)

Zoekresultaten filteren
Datamodellen selecteren

Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

94 Zoekresultaten.

Study SHIP-TREND_metadata_20240913_TREND_TREND1_OPD - t1.visitlog

- 26-10-24 - 10 Formulieren, 1 Itemgroep, 98 Data-elementen, 2 Talen

Itemgroep: t1.visitlog

SHIP Study https://doi.org/10.1093/ije/dyac034

t1.referenz

1 Itemgroep 9 Data-elementen

t1.medhist

1 Itemgroep 11 Data-elementen

t1.weather

1 Itemgroep 21 Data-elementen

t1.intro

1 Itemgroep 58 Data-elementen

t1.bef

1 Itemgroep 2 Data-elementen

t1.bye

1 Itemgroep 11 Data-elementen

Consent RICH study NCT02669589

- 04-07-16 - 1 Formulier, 3 Itemgroepen, 16 Data-elementen, 1 Taal

Itemgroepen: Patient Information, Subsequent consent, Withdrawal of consent

NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

operational data SHIP-Trend-1 welcome, informed, consent

- 20-09-21 - 1 Formulier, 1 Itemgroep, 52 Data-elementen, 2 Talen

Itemgroep: welcome, informed, consent

welcome, informed, consent form of SHIP Study (Study of Health in Pomerania), conducted by the University of Greifswald. SHIP unique domain name TREND.TREND1.OPD.SHIPCore.INTRO. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

operational data SHIP-START-3 welcome, informed, consent

- 20-09-21 - 1 Formulier, 1 Itemgroep, 44 Data-elementen, 2 Talen

Itemgroep: welcome, informed, consent

welcome, informed, consent form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name SHIP.SHIP3.OPD.SHIPCore.INTRO. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617 The English version of this form is under development.

medical examination SHIP-START-3 final discussion, criticism

- 03-07-21 - 1 Formulier, 1 Itemgroep, 44 Data-elementen, 2 Talen

Itemgroep: final discussion, criticism

final discussion, criticism form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name SHIP.SHIP3.MEX.PHYSEXAM.FIN. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617 The English version of this form is under development.

clinic internal medicine B SHIP-START-3 internal medicine consent

- 03-07-21 - 1 Formulier, 1 Itemgroep, 8 Data-elementen, 2 Talen

Itemgroep: internal medicine consent

internal medicine consent form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name SHIP.SHIP3.IMB.OPDB.IMBINTRO. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

clinic internal medicine B SHIP-Trend-1 internal medicine consent

- 18-06-18 - 1 Formulier, 1 Itemgroep, 10 Data-elementen, 2 Talen

Itemgroep: internal medicine consent

internal medicine consent form of SHIP Study (Study of Health in Pomerania), conducted by the University of Greifswald. SHIP unique domain name TREND.TREND1.IMB.OPDB.IMBINTRO. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Pharmacogenetics Research Consent Form

- 11-01-19 - 1 Formulier, 3 Itemgroepen, 12 Data-elementen, 1 Taal

Itemgroepen: Administrative data, Date of Visit/Assessment, PGx Research Consent

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Pharmacogenetics Research Consent Withdrawal

- 11-01-19 - 1 Formulier, 3 Itemgroepen, 10 Data-elementen, 1 Taal

Itemgroepen: Administrative data, Date of Visit/Assessment, PGx Research Withdrawal of Consent

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

medical examination SHIP-Trend-0 final discussion, criticism

- 16-11-17 - 1 Formulier, 1 Itemgroep, 19 Data-elementen, 2 Talen

Itemgroep: final discussion, criticism

final discussion, criticism form of SHIP Study (Study of Health in Pomerania), conducted by the University of Greifswald. SHIP unique domain name SHIP.SHIPTrend0.MEX.PHYSEXAM.FIN. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination DRKS00004652 - Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination

- 11-11-15 - 1 Formulier, 1 Itemgroep, 4 Data-elementen, 2 Talen

Itemgroep: Study termination

Study description: Study documentation part- Study termination. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.

Immunogenicity, safety and reactogenicity of combined hepatitis A / hepatitis B vaccine (TWINRIX ADULT) in healthy children (100565) - Informed Consent for the long-term follow-up

- 16-03-19 - 1 Formulier, 3 Itemgroepen, 17 Data-elementen, 1 Taal

Itemgroepen: Informed Consent for the long-term follow-up, Administrative, Statement by Doctor, Nurse or Project Assistant who conducted the informed consent discussion:

Study ID: 100565 Clinical Study ID: 100565 Study Title: An open study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals' commercially available combined hepatitis A / hepatitis B vaccine (TWINRIX ADULT) containing 720 ELISA units of hepatitis A antigen and 20 µg of hepatitis B surface antigen, administered following a two-dose (0, 6 months) schedule in healthy children between the ages of 1 and 11 years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Phase: phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.